Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for CORT stock have an average target of 41.4, with a low estimate of 29 and a high estimate of 65. The average target predicts an increase of 22.20% from the current stock price of 33.88.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$29	$41.4	$38	$65
Change	-14.40%	+22.20%	+12.16%	+91.85%

Analyst Ratings

The average analyst rating for CORT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	2	2	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Amsellem Piper Sandler	Piper Sandler	Buy Reiterates $35	Buy	Reiterates	$35	+3.31%	Jul 1, 2024
Joon Lee Truist Securities	Truist Securities	Strong Buy Maintains $65	Strong Buy	Maintains	$65	+91.85%	Jun 17, 2024
Joon Lee Truist Securities	Truist Securities	Strong Buy Reiterates $44 → $65	Strong Buy	Reiterates	$44 → $65	+91.85%	Jun 4, 2024
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+18.06%	May 29, 2024
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $38 → $40	Strong Buy	Maintains	$38 → $40	+18.06%	May 2, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

644.79M

Increased by 33.67%

from 482.38M

Revenue Next Year

729.99M

Increased by 13.21%

from 644.79M

EPS This Year

0.98

Increased by 4.39%

from 0.94

EPS Next Year

1.38

Increased by 40.54%

from 0.98

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	306.49M	353.87M	365.98M	401.86M	482.38M	644.79M	729.99M	970.92M	917.94M	1.05B
Revenue Growth	21.99%	15.46%	3.42%	9.80%	20.04%	33.67%	13.21%	33.00%	-5.46%	14.50%
EPS	0.77	0.85	0.89	0.87	0.94	0.98	1.38	2.72	2.27	3.07
EPS Growth	28.33%	10.39%	4.71%	-2.25%	8.05%	4.39%	40.54%	96.93%	-16.43%	35.28%
Forward PE	-	-	-	-	-	34.53	24.57	12.48	14.93	11.04
No. Analysts	-	-	-	-	-	7	7	6	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	672.9M	865.3M	1.5B	1.0B	1.3B
Avg	644.8M	730.0M	970.9M	917.9M	1.1B
Low	608.2M	622.3M	762.4M	849.8M	915.8M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	39.5%	34.2%	107.5%	4.0%	38.7%
Avg	33.7%	13.2%	33.0%	-5.5%	14.5%
Low	26.1%	-3.5%	4.4%	-12.5%	-0.2%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	1.17	1.90	5.57	2.55	3.47
Avg	0.98	1.38	2.72	2.27	3.07
Low	0.84	0.54	1.14	1.98	2.67

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	24.0%	93.7%	303.5%	-6.0%	52.7%
Avg	4.4%	40.5%	96.9%	-16.4%	35.3%
Low	-10.3%	-45.1%	-17.6%	-27.1%	17.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.